| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―09 |
Comment on ‘Risk of inflammatory dermatoses following COVID-19 infection: a cohort study of 204,241 patients’: considerations regarding causal inference |
Xue Xu, Rongying Wang, Qianqian Zhang, Yulin Zou |
| 2 |
[GO] |
2026―Feb―12 |
Comment on “Risk of Inflammatory Dermatoses Following Covid-19 Infection: A Cohort Study of 204,241 Patients” |
Kishankumar Mahida, Snehal Rajendra Jagtap |
| 3 |
[GO] |
2026―Jan―28 |
Risk of Inflammatory Dermatoses Following Covid-19 Infection: A cohort Study of 204,241 Patients |
Danielle Bar, Ilia Beberashvili |
| 4 |
[GO] |
2025―Aug―15 |
42,089 fewer skin tumours diagnosed in England during the 2020 COVID pandemic: greatest reductions in melanoma in-situ, stage I melanomas and basal cell carcinomas |
Omsin Srimudkul, Nick J Levell, Birgitta van Bodegraven, Khaylen Mistry, Zoe C Venables |
| 5 |
[GO] |
2025―Feb―05 |
The impact of COVID-19 on ultraviolet phototherapy services in Scotland |
Ewan Eadie |
| 6 |
[GO] |
2025―Jan―31 |
Is a hybrid skin cancer surveillance service for organ transplant recipients feasible?: Lessons from the COVID-19 pandemic |
Jaimie Oldham, Pia Tookey, Rebecca Morgan, Sharumilan Ravindran, Aaron Sosah, Zeeshaan-ul Hasan, Rebeca Goiriz, Catherine Harwood |
| 7 |
[GO] |
2024―Sep―20 |
Impact of the COVID-19 pandemic on telogen effluvium: a nationwide multicentre interrupted time series study |
Jee Woong Choi, Hyoung Soo Park, Sang Seok Kim, Chang-Hun Huh, Ohsang Kwon, Bark-Lynn Lew, Moon Bum Kim |
| 8 |
[GO] |
2024―Aug―26 |
Lichen planus following Covid-19 vaccination: a narrative review |
Michela D’Agostino, Fabrizio Martora, Matteo Megna, Maddalena Napolitano, Luca Potestio |
| 9 |
[GO] |
2024―Aug―22 |
Humoral immunity after a booster dose of COVID-19 vaccine in patients with psoriasis treated with methotrexate and biologics: a cohort study |
Amanda Kvist-Hansen, Cecilie Bo Hansen, Sebastian Rask Hamm, Laura Pérez-Alós, Claus Zachariae, Susanne Dam Nielsen, Peter Garred, Lone Skov |
| 10 |
[GO] |
2024―Jun―05 |
Parry-Romberg syndrome following COVID-19 vaccination |
Deborah De Caux, Randa Akel |
| 11 |
[GO] |
2024―Apr―06 |
Patient-Led Skin Cancer Teledermatology without Dermoscopy during the Covid pandemic: Important lessons for the development of future patient-facing teledermatology & AI-assisted self-diagnosis |
Omar M E Ali, Beth Wright, Charlotte Goodhead, Philip J Hampton |
| 12 |
[GO] |
2024―Feb―20 |
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature |
Fabrizio Martora, Matteo Megna, Teresa Battista, Massimiliano Scalvenzi, Alessia Villani, Sara Cacciapuoti, Luca Potestio |
| 13 |
[GO] |
2023―Dec―11 |
Comment on ‘Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States’ |
Luca Potestio, Fabrizio Martora, Matteo Megna, Alessia Villani, Sara Cacciapuoti |
| 14 |
[GO] |
2023―Dec―07 |
Positive Perceptions Towards Virtual Didactics During The COVID-19 Pandemic: A Survey Assessment of Dermatology Residents |
Marc Schlessel, Mio Nakamura, Frank Wang |
| 15 |
[GO] |
2023―Nov―15 |
Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States |
Inga Muser, Josh Gallop, Jatin Narang, Elizabeth M Flatley, Joan Tamburro, Maureen Riegert, Anthony P Fernandez |
| 16 |
[GO] |
2023―Nov―13 |
Comment on ‘Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics’ |
Sibel Altunisik Toplu, Nihal Altunisik |
| 17 |
[GO] |
2023―Nov―08 |
Vascular cutaneous manifestations of COVID-19 and RNA viral pathogens: a systematic review |
Jamie L Karch, Chiamaka L Okorie, Mayra B C Maymone, Melissa Laughter, Neelam A Vashi |
| 18 |
[GO] |
2023―Aug―18 |
Evaluating medical undergraduates’ and dermatology faculty members’ perceptions of the use of three-dimensional (3D) images in the learning of dermatology in a time of COVID-19 - a mixed methods study |
Delwyn Z J Lim, Yen Loo Lim, Sze-Hon Chua, Ziying Vanessa Lim |
| 19 |
[GO] |
2023―Jan―20 |
Comment on ‘Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination’ |
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, Luca Potestio |
| 20 |
[GO] |
2023―Jan―20 |
Comment on ‘Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine’ |
Luca Potestio, Lucia Genco, Matteo Noto, Gabriella Fabbrocini, Teresa Battista, Fabrizio Martora |
| 21 |
[GO] |
2022―Sep―02 |
Immune response to Covid-19 mRNA vaccination in psoriasis patients undergoing treatment with biologics |
Matteo Megna, Luca Potestio, Teresa Battista, Elisa Camela, Lucia Genco, Matteo Noto, Gabriella Fabbrocini, Fabrizio Martora |
| 22 |
[GO] |
2022―Sep―02 |
Reply to “Morphoea following COVID-19 Vaccination” |
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, Gabriella Fabbrocini, Luca Potestio |
| 23 |
[GO] |
2022―Aug―08 |
Morphoea and COVID-19 Vaccination |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 24 |
[GO] |
2022―Aug―08 |
Immune response to
SARS-CoV
-2
mRNA
vaccine in psoriasis patients treated with biologics |
Maruška Marovt, Petra Deželak, Robert Ekart, Pij B. Marko |
| 25 |
[GO] |
2022―Jul―30 |
Morphoea following COVID-19 Vaccination |
Dawn A.Q. Oh, Yee Kiat Heng, Shang-Ian Tee |
| 26 |
[GO] |
2022―Jul―07 |
Patients’ satisfaction with remote dermatology consultations during Covid-19 pandemic. Response to “A qualitative assessment of patient satisfaction with remote dermatology consultations utilised during the
UK
's first wave of the Covid-19 pandemic in a single secondary care Dermatology department” |
Fabrizio Martora, Angelo Ruggiero, Gabriella Fabbrocini, Alessia Villani |
| 27 |
[GO] |
2022―Jul―01 |
Shaping the Future of Teledermatology: A Literature Review of Patient and Provider Satisfaction with Synchronous Teledermatology during the
COVID
-19 Pandemic |
John Miller, Elizabeth Jones |
| 28 |
[GO] |
2022―Jun―21 |
The impact of
COVID
-19 pandemic on non-melanoma skin cancers: report of a Southern Italy referral centre |
Angelo Ruggiero, Fabrizio Martora, Luigi Fornaro, Gianluca Guerrasio, Francesca di Vico, Gabriella Fabbrocini, Massimiliano Scalvenzi, Alessia Villani |
| 29 |
[GO] |
2022―Jun―14 |
A qualitative assessment of patient satisfaction with remote dermatology consultations utilised during the
UK
’s first wave of the Covid-19 pandemic in a single secondary care Dermatology department |
Amy Livesey, Alice Plant, Roshni Simmonds, Charles Mitchell |
| 30 |
[GO] |
2022―Jun―03 |
Video and telephone teledermatology visits during COVID-19 in comparison: patients’ satisfaction, doubts, and concerns |
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, Fabrizio Martora |
| 31 |
[GO] |
2022―May―29 |
Cutaneous adverse reactions to the new oral antiviral drugs against SarS-CoV-2 |
Madalena Pupo Correia, Sónia Fernandes, Paulo Filipe |
| 32 |
[GO] |
2022―May―28 |
Response to ‘Unexpected consequences of SARS-CoV-2 pandemic: scabies infestation’ |
Fabrizio Martora, Gabriella Fabbrocini, Lucia Gallo, Angelo Ruggiero |
| 33 |
[GO] |
2022―Apr―15 |
Response to ‘Influence of COVID-19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital’: The Impact of Covid-19 on Non-Melanoma Skin Cancer: The experience of an Irish Dermatology Department |
Anna Wolinska, Gregg Murray, Stephenie Bowe, Sinead Collins, Cliona Feighery, Aizuri Murad |
| 34 |
[GO] |
2022―Mar―22 |
Response to ‘The influence of the Covid-19 pandemic on Breslow thickness and outpatient malignant melanoma service provision in an Irish dermatology centre’ - The Number Needed to Treat Metric: A further marker of the impact of Covid-19 on Malignant Melanomas |
Aoife Granahan, Hafsah Sazali, Olga Tummon, Orla Costigan, Louise Fleming, Blaithin Moriarty, Aoife Lally |
| 35 |
[GO] |
2022―Mar―13 |
Response to ‘Unexpected consequences of
SARS-CoV
-2 pandemic: Scabies infestation’ |
Dursun Turkmen, Nihal Altunisik |
| 36 |
[GO] |
2022―Feb―22 |
Unexpected consequences of SARS-CoV-2 pandemic: Scabies infestation |
Laoise Griffin, Emily Pender, Mary Laing, Trevor Markham |
| 37 |
[GO] |
2022―Feb―21 |
The influence of the Covid-19 pandemic on Breslow thickness and outpatient malignant melanoma service provision in an Irish dermatology centre |
Stephanie Bowe, Anna Wolinska, Gregg Murray, Ciara Malone, Cliona Feighery, Muireann Roche |
| 38 |
[GO] |
2022―Feb―21 |
Response to “Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine” |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 39 |
[GO] |
2022―Feb―12 |
Response to ‘Effects of the COVID-19 pandemic on head lice and scabies infestation dynamics: a population-based study in France’ |
Dursun Turkmen, Nihal Altunisik |
| 40 |
[GO] |
2022―Jan―12 |
Living with Multiple Chemical Sensitivity during the Covid-19 pandemic: a patient's perspective |
Sareena Gajebasia, Sanaa Butt, Aandrew Affleck |
| 41 |
[GO] |
2022―Jan―03 |
Sarcoidal immune reaction following SARS-CoV-2 vaccination |
Nessr Abu Rached, Rita Mansour, Laura Susok, Sabrina Fried, Nasreen Abolmaali, Yi-Pei Lee, Thilo Gambichler |
| 42 |
[GO] |
2021―Dec―23 |
A Multi-centre Qualitative Study of Patient Skin Surgery Experience during the Covid-19 Pandemic in the United Kingdom |
Iqra Ashraf, Yasmin Nikookam, Albert Hong, Ashima Lowe, Jasmine Mann, Mona Ebadian, Dushyanth Gnanappiragasam, Rachel Abbott, David Veitch, Aaron Wernham |
| 43 |
[GO] |
2021―Dec―10 |
Effects of the Covid-19 pandemic on head lice and scabies infestation dynamics: a population based study in France |
T. Launay, I. Bardoulat, M. Lemaitre, T. Blanchon, L. Fardet |
| 44 |
[GO] |
2021―Nov―08 |
Phenotypic spectrum of serious cutaneous only adverse event following immunisation with COVID-19 vaccines: a multi-centre case series and literature review |
M. Balogun, D. Millette, V. Yip, S.A. Chan, P. Lee, N. Gamal, N. Hashim, D. Phillips, M. Walsh, P. Trehan, L. Hanna-Bashara, A. Abdullah, A. Wernham, S. Tso |
| 45 |
[GO] |
2021―Nov―03 |
Comparison of Cost Changes for Dermatology Residency Applications due to the COVID-19 Pandemic |
M. Gorgy, S. Shah, S. Arbuiso, A. Cline, M. Russo |
| 46 |
[GO] |
2021―Nov―03 |
Erythema annulare centrifugum induced by SARS-CoV-2 vaccination |
J.C. Kim, S.Y. Lee, S.Y. Kang, H.O. Kim, C.W. Park, B.Y. Chung |
| 47 |
[GO] |
2021―Oct―21 |
The Virtual Men’s Shed - a pilot of online access to skin cancer education for a high-risk population in the COVID-19 era |
L. Lynch, C. O’Connor, M. Bennett, M. Murphy |
| 48 |
[GO] |
2021―Oct―21 |
Evaluating paediatric dermatology telephone clinics during COVID-19 from a dual clinician and patient perspective: A prospective study |
A. Lowe, S. Dawood, A. Al-Tayeb, P. Hancock, A. Pararajasingam, F. Ali, R.G. Goodwin |
| 49 |
[GO] |
2021―Oct―08 |
Abrupt onset of Sweet syndrome, Pityriasis Rubra Pilaris, Pityriasis lichenoides et varioliformis acuta, and Erythema multiforme unraveling a possible common trigger: Covid-19 vaccine |
A. Sechi, E. Pierobon, E. Pezzolo, L. Germi, G. Trevisan, D. Zardo, G. Riva, S. Mondino, L. Naldi |
| 50 |
[GO] |
2021―Oct―07 |
The influence of COVID-19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital |
A. Conde-Taboada, Á. Iglesias-Puzas, A. Sirgado, L. Campos, I. Serrano, E. López-Bran |
| 51 |
[GO] |
2021―Oct―07 |
Acute urticaria alone after CoronaVac COVID-19 vaccination should not be contraindicated for revaccination |
J. Triwatcharikorn, T. Puaratana-arunkon, P. Punyaratabandhu, P. Mongkolpathumrat, S. Palapinyo, S. Buranapraditkul, P. Rerknimitr, J. Klaewsongkram |
| 52 |
[GO] |
2021―Sep―30 |
Favipiravir induce cutaneous adverse reactions in COVID-19-infected patients |
P. Punyaratabandhu, S. Vanitchpongphan |
| 53 |
[GO] |
2021―Sep―24 |
Teledermatology 2 week wait skin cancer referrals during the COVID-19 pandemic: A service evaluation |
L. Elliott, M. Sharma |
| 54 |
[GO] |
2021―Sep―24 |
The effect of COVID-19-related changes on geographic outcomes in the 2021 dermatology residency match |
K.M. Mulligan, D.X. Zheng, J. Narang, A. Eversman, M.K. Kalra, F. Morgan, E.E. Obi, W. Osei-Koomson, E.R. Russell, A.H. Wei, T.R. Sharma |
| 55 |
[GO] |
2021―Sep―22 |
Response to "A case of de novo generalised pustular psoriasis following Oxford-AstraZeneca COVID-19 Vaccine": Possible role for Type I interferons |
B. Awada, L. Abdullah, M. Kurban, O. Abbas |
| 56 |
[GO] |
2021―Sep―09 |
Response to "Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?": Type I interferons as possible link between COVID-19 vaccine and vitiligo |
L. Abdullah, B. Awada, M. Kurban, O. Abbas |
| 57 |
[GO] |
2021―Sep―05 |
Generalized Bullous Fixed Drug Eruption after ChAdOx1 nCoV-19 Vaccination |
K. Wantavornprasert, N. Noppakun, J. Klaewsongkram, P. Rerknimitr |
| 58 |
[GO] |
2021―Aug―25 |
COVID-19 vaccination and exanthema like eruption |
R. Mungmunpuntipantip, V. Wiwanitkit |
| 59 |
[GO] |
2021―Aug―20 |
Allergic and Cutaneous reactions following Inactivated SARS-CoV-2 vaccine (CoronaVac®) in Healthcare workers |
K. Durmaz, S. A. Temiz, K. Zuhal, Recep Dursun, Ayman Abdelmaksoud |
| 60 |
[GO] |
2021―Aug―19 |
Patient characteristics in tardive Covid-19 pseudoperniosis - a case series of 16 patients |
B. Ganatra, R. Amarnani, Y. Alfallouji, K. Dear, E. Twigg, J.-P. Westwood, B. Goulden, V. Morris, T. Hillman, S. Goolamali, R. Sidwell, P. Ellery, G. Kravvas, C. Bunker |
| 61 |
[GO] |
2021―Aug―16 |
Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination |
P.N. Lim, G. Wylie |
| 62 |
[GO] |
2021―Aug―16 |
A case of de novo generalised pustular psoriasis following Oxford-AstraZeneca COVID-19 Vaccine |
S. Elamin, F. Hinds, J. Tolland |
| 63 |
[GO] |
2021―Aug―11 |
Pityriasis Rubra Pilaris like eruption following administration of the BNT163b2 (Pfizer BioNTech) mRNA COVID-19 vaccine |
M.K. Hunjan, C. Roberts, S. Karim, J. Hague |
| 64 |
[GO] |
2021―Jul―26 |
Dupilumab in adolescents with moderate-to-severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic |
K. Hansel, C. Patruno, E. Antonelli, G. Dal Bello, M. Napolitano, G. Fabbrocini, T. Grieco, G. Pellacani, M.C. Fargnoli, M. Esposito, V. Piras, M. Zucca, G. Girolomoni, L. Stingeni |
| 65 |
[GO] |
2021―Jul―22 |
Induction and exacerbation of subacute cutaneous lupus erythematosus following messenger-RNA or adenoviral-vector based SARS-CoV-2 vaccination |
A. Kreuter, M.J. Licciardi-Fernandez, S.-N. Burmann, B. Burkert, F. Oellig, A.-L. Michalowitz |
| 66 |
[GO] |
2021―Jul―20 |
Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: A six-month retrospective study |
I. Papadimitriou, K. Bakirtzi, E. Sotiriou, E. Vakirlis, D. Hatzibougias, D. Ioannides |
| 67 |
[GO] |
2021―Jul―08 |
Exploring the implications of the first COVID-19 lockdown on patients with melanoma: a national survey |
S.A. Raza, D. Cannon, G. Nuttall, F.R. Ali |
| 68 |
[GO] |
2021―Jul―08 |
Vesicolous-bullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature |
P. Coto-Segura, M. Fernández-Prada, M. Mir-Bonafé, B. García-García, I. González-Iglesias, P. Alonso-Penanes, M González-Guerrero, A. Gutiérrez-Palacios, E. Miranda-Martínez, F. Martinón-Torres |
| 69 |
[GO] |
2021―Jul―08 |
Vitiligo in a COVID-19 vaccinated patient with ulcerative colitis: A coincidence? |
H. Aktaş, G. Ertuğrul |
| 70 |
[GO] |
2021―Jun―30 |
Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination |
R. Ramessur, N. Saffar, B. Czako, A. Agarwal, K. Batta |
| 71 |
[GO] |
2021―Jun―11 |
Every cloud has a silver lining: the environmental benefit of teledermatology during the COVID-19 pandemic |
G. O’Connell, C. O’Connor, M. Murphy |
| 72 |
[GO] |
2021―Jun―11 |
Asymmetric cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance |
V. Kharkar, T. Vishwanath, S. Mahajan, R. Joshi, P. Gole |
| 73 |
[GO] |
2021―Jun―04 |
Evaluating the Impact of the COVID-19 Pandemic and State Restrictions on Public Interest in Tanning: A Google Trends Analysis |
R. Drozdowski, C. Gronbeck, H. Feng |
| 74 |
[GO] |
2021―Jun―03 |
In-depth, single-centre, analysis of changes in emergency service access after the spread of COVID-19 across Italy |
T. Ferrari, C. Zengarini, F. Bardazzi, A. Pileri |
| 75 |
[GO] |
2021―Jun―03 |
Mask induced dermatoses during COVID-19 pandemic: A questionnaire-based study in 12 hospitals of Korea |
S.Y. Choi, J.Y. Hong, H.J. Kim, G.-Y. Lee, C.S. Hyun, H.J. Jung, C.H. Bang, D.H. Lee, M.-S. Jue, H.O. Kim, E.J. Park, J.Y. Ko, S.W. Son |
| 76 |
[GO] |
2021―Jun―03 |
Radiation recall dermatitis triggered by inactivated COVID-19 vaccine |
E. Afacan, B. Öğüt, P. Üstün, E. Şentürk, O. Yazıcı, E. Adışen |
| 77 |
[GO] |
2021―Jun―03 |
Covid-19 vaccine induced Steven-Johnson syndrome: a case report |
S. Dash, C.S. Sirka, S. Mishra, P. Viswan |
| 78 |
[GO] |
2021―May―28 |
Short back and sides: photodermatosis presentation related to hairstyling during the COVID-19 pandemic |
D.W. Middleton, H.L. Hunter |
| 79 |
[GO] |
2021―May―10 |
Attendance at an Emergency Dermatology consultation during one year of the COVID-19 pandemic: towards new sensitivities? |
J. Ortiz-Álvarez, A.J. Durán-Romero, J.C. Hernández-Rodríguez, M. Sendín-Martin, J. Conejo-Mir, J.J. Pereyra Rodriguez |
| 80 |
[GO] |
2021―May―10 |
COVID-19 vaccine does not trigger psoriasis flares in psoriatic patients treated with apremilast |
A. Pacifico, A. d’Arino, P.D.M. Pigatto, P. Malagoli, G. Damiani |
| 81 |
[GO] |
2021―Apr―29 |
A flare of pre-existing erythema multiforme post BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine |
S. Nawimana, M.J. Lavery, R. Parslew, L. Stewart |
| 82 |
[GO] |
2021―Apr―25 |
Ivermectin in Dermatology: why it ‘mite’ be useless against COVID-19 |
D. Roche, C. O’Connor, M. Murphy |
| 83 |
[GO] |
2021―Apr―19 |
Periorbital Erythema is a Common Cutaneous Manifestation in COVID-19 |
K. Terzi, S. Kesici, Y. Özsürekci, Benan Bayrakci |
| 84 |
[GO] |
2021―Apr―17 |
Mohs Micrographic Surgery outcomes following virtual consultations during COVID-19 pandemic |
P. Nicholson, F.R. Ali, R. Mallipeddi |
| 85 |
[GO] |
2021―Apr―17 |
Remote consultations for patients with hidradenitis suppurativa during the COVID-19 pandemic: a single centre experience |
N.P. Patel |
| 86 |
[GO] |
2021―Apr―10 |
COVID-19 and melanoma surgery in a dermo-oncology center in Italy |
E. Dika, A. Barisani, C. Baraldi, F. Pepe, A. Patrizi, S. Vaccari |
| 87 |
[GO] |
2021―Apr―09 |
Ribonucleic acid (RNA) COVID-19 vaccine associated cutaneous adverse drug events: a case series of two patients |
M. Lam, M. Egail, A.J. Bedlow, S. Tso |
| 88 |
[GO] |
2021―Mar―15 |
Dietary deprivation during the COVID-19 pandemic producing acquired vulval zinc-deficiency dermatitis |
M. James, M. Philippidou, M. Duncan, S. Goolamali, T. Basu, S. Walsh |
| 89 |
[GO] |
2021―Mar―05 |
COVID-19 vaccination and psoriatic patients under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers |
G. Damiani, F. Allocco, P.o Malagoli |
| 90 |
[GO] |
2021―Feb―27 |
Dermatologists as COVID-19 stigma recipients |
G. Kyriakou, S. Papanikolaou, C. Bimbi |
| 91 |
[GO] |
2021―Feb―25 |
Dealing with suspended new routine general dermatology referrals during the COVID-19 pandemic: a virtual model from our local departmental experience |
A. Pararajasingam, A. Lowe, W. Khan, P. Hancock, N. Stone |
| 92 |
[GO] |
2021―Feb―12 |
Mask-Related Acne in the COVID-19 Pandemic: An Analysis of Twitter Posts and Influencers |
R. Drozdowski, C. Gronbeck, H. Feng |
| 93 |
[GO] |
2021―Feb―01 |
Chilblains and COVID-19: Can recent epidemiological data shed light on the etiological debate? |
M. Baeck, A. Herman |
| 94 |
[GO] |
2021―Jan―29 |
COVID-19 induced Toxic Epidermal Necrolysis |
I. Narang, A.P. Panthagani, M. Lewis, B. Chohan, A. Ferguson, R. Nambi |
| 95 |
[GO] |
2021―Jan―23 |
Toxic erythema as the first sign of COVID-19 infection |
M.K. Hunjan, L. Zuzarte, A. Bardhan, S. Karim, A. Heagarty |
| 96 |
[GO] |
2020―Dec―26 |
The impact of COVID-19 on dermatology outpatient services in England in 2020 |
L.S. Ibrahim, Z.C. Venables, N.J. Levell |
| 97 |
[GO] |
2020―Nov―29 |
Sense and sensibility: an Irish dermatology department in the era of COVID-19 |
C. O’Connor, G. O’Connell, E. Nic Dhonncha, L. Roche, C. Quinlan, L.A. Murphy, C. Gleeson, M. Bennett, J. Bourke, M. Murphy |
| 98 |
[GO] |
2020―Nov―20 |
Changes in UK dermatological surgery during the COVID-19 pandemic |
T.M. Tian, V. Ghura |
| 99 |
[GO] |
2020―Nov―18 |
Skin manifestations of COVID-19 in children: Part 3 |
D. Andina, A. Belloni-Fortina, C. Bodemer, E. Bonifazi, A. Chiriac, I. Colmenero, A. Diociaiuti, M. El-Hachem, L. Fertita, D. Gysel, A. Hernández-Martín, T. Hubiche, C. Luca, L. Martos-Cabrera, A. Maruani, F. Mazzotta, A. D. Akkaya, M. Casals, J. Ferrando, R. Grimalt, I. Grozdev, V. Kinsler, M. A. Morren, M. Munisami, A. Nanda, M. P. Novoa, H. Ott, S. Pasmans, C. Salavastru, V. Zawar, A. Torrelo |
| 100 |
[GO] |
2020―Nov―15 |
Electronic learning for Healthcare (e-LfH) e-Dermatology modules as a key educational tool for trainees during the COVID-19 pandemic: a regional experience |
F.M. Ali, J. Caesar, M.M.U. Chowdhury |
| 101 |
[GO] |
2020―Nov―12 |
Skin manifestations of COVID-19 in children: Part 1 |
D. Andina, A. Belloni-Fortina, C. Bodemer, E. Bonifazi, A. Chiriac, I. Colmenero, A. Diociaiuti, M. El-Hachem, L. Fertita, D. Gysel, A. Hernández-Martín, T. Hubiche, C. Luca, L. Martos-Cabrera, A. Maruani, F. Mazzotta, A. D. Akkaya, M. Casals, J. Ferrando, R. Grimalt, I. Grozdev, V. Kinsler, M. A. Morren, M. Munisami, A. Nanda, M. P. Novoa, H. Ott, S. Pasmans, C. Salavastru, V. Zawar, A. Torrelo |
| 102 |
[GO] |
2020―Nov―09 |
Skin manifestations of COVID-19 in children: Part 2 |
D. Andina, A. Belloni-Fortina, C. Bodemer, E. Bonifazi, A. Chiriac, I. Colmenero, A. Diociaiuti, M. El-Hachem, L. Fertita, D. Gysel, A. Hernández-Martín, T. Hubiche, C. Luca, L. Martos-Cabrera, A. Maruani, F. Mazzotta, A. D. Akkaya, M. Casals, J. Ferrando, R. Grimalt, I. Grozdev, V. Kinsler, M. A. Morren, M. Munisami, A. Nanda, M. P. Novoa, H. Ott, S. Pasmans, C. Salavastru, V. Zawar, A. Torrelo |
| 103 |
[GO] |
2020―Nov―01 |
A paradigm shift in trainee confidence in teledermatology and virtual working during the Covid-19 pandemic: results of a follow-up UK-wide survey |
A. Lowe, A. Pararajasingam, R.G. Goodwin |
| 104 |
[GO] |
2020―Oct―24 |
An evaluation of dermatology patients shielding during the COVID-19 outbreak |
S.S. Khan, C.L. Marshall, K.A. Stylianou, E. McMullen, C.E.M. Griffiths, R.B. Warren, H.J.A. Hunter |
| 105 |
[GO] |
2020―Oct―24 |
“Mask tinea”: tinea faciei possibly potentiated by prolonged mask usage during the COVID-19 pandemic |
A. Agarwal, T. Hassanandani, A. Das, M. Panda, S. Chakravorty |
| 106 |
[GO] |
2020―Sep―25 |
Shedding light on the myths of ultraviolet radiation in the Covid-19 pandemic |
C. O’Connor, C. Courtney, M. Murphy |
| 107 |
[GO] |
2020―Sep―11 |
Palmar digital vein thrombosis in a COVID-19 patient |
A. Connolly, S. Walsh, R. Arya |
| 108 |
[GO] |
2020―Aug―28 |
Patient perceptions of Mohs micrographic surgery during the COVID-19 pandemic and lessons for the next outbreak |
P. Nicholson, F.R. Ali, R. Patalay, E. Craythorne, R. Mallipeddi |
| 109 |
[GO] |
2020―Aug―16 |
View from Portsmouth during the COVID-19 pandemic: remote dermatology work |
A. Haworth |
| 110 |
[GO] |
2020―Aug―05 |
Reduction in Skin Cancer Diagnoses in the UK during COVID-19 Pandemic |
T.W. Andrew, M. Alrawi, P. Lovat |
| 111 |
[GO] |
2020―Jul―29 |
COVID-19 associated herpetic gingivostomatitis |
T. Kämmerer, J. Walch, M. Flaig, L.E. French |
| 112 |
[GO] |
2020―Jul―29 |
Teledermoscopy as a community based diagnostic test in the era of Covid-19? |
A. Lowe, A. Atwan, C.M. Mills |
| 113 |
[GO] |
2020―Jul―24 |
Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study |
L.F. Kiely, E. Moloney, G. O’Sullivan, J.A. Eustace, J. Gallagher, J.F. Bourke |
| 114 |
[GO] |
2020―Jul―19 |
COVID-19: Challenges and solutions for the future of UK dermatology undergraduate curriculum delivery |
O. Oki, S. Shah, L. Scrivens, J. Guckian |
| 115 |
[GO] |
2020―Jul―08 |
Immune checkpoint inhibition in the era of COVID-19 |
J. Kurzhals, P. Terheyden, E.A. Langan |
| 116 |
[GO] |
2020―Jul―06 |
Mental health and dermatology practice in the COVID-19 pandemic |
G. Lada, P. S. Talbot, A. Bewley, C. E. Kleyn |
| 117 |
[GO] |
2020―Jul―03 |
Learning New Ways of Teaching and Assessment - The Impact of Covid-19 on Undergraduate Dermatology Education |
E. Nic Dhonncha, M. Murphy |
| 118 |
[GO] |
2020―Jul―03 |
Dermatology residents and COVID-19: life behind the frontlines |
F. Viviani, T. Ferrari, M. Mussi, C. Zengarini, G. Orioni |
| 119 |
[GO] |
2020―Jul―01 |
Potential use of Turmeric in COVID-19 |
H. Gupta, M. Gupta, S. Bhargava |
| 120 |
[GO] |
2020―Jul―01 |
A UK-wide survey looking at teaching and trainee confidence in teledermatology: A vital gap in a Covid-19 induced era of rapid digital transformation? |
A. Lowe, A. Pararajasingam, R. Goodwin |
| 121 |
[GO] |
2020―Jun―29 |
“Cell Phone Acne” Epidemic during COVID-19 Pandemic |
M. Singh, M. Pawar, A. Maheshwari, A. Bothra, N. Khunger |
| 122 |
[GO] |
2020―Jun―27 |
Impact of COVID-19 on Mohs micrographic surgery: UK-wide survey and recommendations for practice |
P. Nicholson, F.R. Ali, R. Mallipeddi |
| 123 |
[GO] |
2020―Jun―23 |
View from Portsmouth during COVID-19 pandemic ward work |
A. R. Shipman |
| 124 |
[GO] |
2020―Jun―05 |
Melanoma defies ‘lockdown’: ongoing detection during Covid-19 in central London |
A.A. Schauer, E.L. Kulakov, C.L. Martyn-Simmons, C.B. Bunker, E. Edmonds |
| 125 |
[GO] |
2020―Jun―03 |
Dermatological insights from Google Trends: what does the public think is important during COVID-19 lockdown? |
T. Searle, F. Al-Niaimi, F.R. Ali |
| 126 |
[GO] |
2020―May―21 |
Reply to “Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital”: Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection |
M. Llamas-Velasco, P. Chicharro, P. Rodríguez-Jiménez, L. Martos-Cabrera, D. De Argila, M. Fernández-Figueras, J. Fraga |
| 127 |
[GO] |
2020―May―21 |
Makeshift face shield for healthcare professionals during the COVID-19 pandemic |
S. Gupta, R. S. Jangra, S. Gupta, A. V. Gujrathi, A. Sharma |
| 128 |
[GO] |
2020―May―18 |
Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain |
A. Saenz Aguirre, F.J. De la Torre Gomar, P. Rosés-Gibert, J. Gimeno Castillo, Z. Martinez de Lagrán Alvarez de Arcay, R. Gonzalez-Perez |
| 129 |
[GO] |
2020―May―16 |
A targeted response to the COVID-19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals |
E. Corden, A. Rogers, W.A. Woo, R. Simmonds, C. Mitchell |
| 130 |
[GO] |
2020―May―14 |
Cutaneous manifestations in COVID-19: Family cluster of Urticarial Rash |
R. Cepeda-Valdes, D. Carrion-Alvarez, A. Trejo-Castro, M. Hernandez-Torre, J. Salas-Alanis |
| 131 |
[GO] |
2020―May―09 |
Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings |
J. Jimenez-Cauhe, D. Ortega-Quijano, I. Carretero-Barrio, A. Suarez-Valle, D. Saceda-Corralo, C. Moreno-Garcia del Real, D. Fernandez-Nieto |
| 132 |
[GO] |
2020―May―08 |
Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital |
D. Fernandez-Nieto, D. Ortega-Quijano, J. Jimenez-Cauhe, P. Burgos-Blasco, D. de Perosanz-Lobo, A. Suarez-Valle, J.L. Cortes-Cuevas, I. Carretero, C.M. Garcia Del Real, M. Fernandez-Guarino |
| 133 |
[GO] |
2020―May―05 |
Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic |
J. López-Robles, I. de la Hera, J. Pardo, J. Martínez, E. Cutillas-Marco |
| 134 |
[GO] |
2020―May―05 |
Observations about sexual and other routes of SARS-CoV-2 transmission and its prevention |
A.L. Tatu, T. Nadasdy, L.C. Nwabudike |
| 135 |
[GO] |
2020―May―02 |
Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy |
G. Tosti, A. Barisani, P. Queirolo, E. Pennacchioli, L. Villa, A.M. Lodeserto, S. Vaccari |
| 136 |
[GO] |
2020―May―02 |
Use of transparent curtains on bedside of COVID-19 patients |
S. Gupta, S. Gupta, A.V. Gujrathi |
| 137 |
[GO] |
2020―May―01 |
Comment on ‘Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East’: pernio unrelated to COVID-19 |
I. Torres-Navarro, C. Abril-Pérez, J. Roca-Ginés, J. Sánchez-Arráez, R. Botella-Estrada, Montserrat Évole-Buselli |
| 138 |
[GO] |
2020―Apr―18 |
A novel clinical set up for examining healthy dermatology outpatients in time of Covid-19 |
S. Gupta, R.S. Jangra, A.V. Gujrathi, A. Mahendra, R. Singla, A. Sharma, S. Gupta |
| 139 |
[GO] |
2020―Apr―18 |
Telemedicine and support groups in order to improve the adherence to treatment and health related quality of life in patients affected by inflammatory skin conditions during COVID-19 emergency |
C. Marasca, A. Ruggiero, G. Fontanella, M. Ferrillo, G. Fabbrocini, A. Villani |
| 140 |
[GO] |
2020―Apr―18 |
Screen mirroring, screen casting and screen sharing during COVID-19: What a dermatologist should know |
D. Jakhar, I. Kaur, S. Kaul |
| 141 |
[GO] |
2020―Apr―17 |
A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East |
A. Alramthan, W. Aldaraji |
| 142 |
[GO] |
2020―Apr―03 |
WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side |
J. Deepak, K. Subuhi, K. Ishmeet |
